Home / Vaccines & Immunizations (page 3)

Vaccines & Immunizations

Sanofi and Merck End Joint Vaccines Venture in Europe

KENILWORTH, N.J. & LYON, France–(BUSINESS WIRE)–Sanofi Pasteur and Merck, known as MSD outside the United States and Canada, today announced their intent to end their joint vaccines operations in Europe. Upon concluding their joint venture, both companies plan to integrate their respective European vaccine businesses into their operations, independently manage …

Read More »

Hemispherx Biopharma Exploring Possible Research Programs in Zika Virus

Philadelphia, PA, Tuesday, February 09, 2016: Hemispherx Biopharma, Inc. (NYSE MKT: HEB) announced today that it is beginning to consider study designs for potential tests of the activity and potential uses of its natural alpha interferon (Alferon® N and Alferon® LDO) and rintatolimod (Ampligen®) drug formulations against the Zika virus. The …

Read More »

City of Hope and Fortress Biotech Form DiaVax Biosciences to Develop New Vaccines

A new company has been formed to develop two novel vaccines against cytomegalovirus (CMV) infection, a life-threatening illness in people with weakened or underdeveloped immune systems, such as cancer patients and developing fetuses. City of Hope and Fortress Biotech have reached an agreement to form the new subsidiary company, called …

Read More »

Bristol-Myers Squibb Signs a Prostate Cancer Vaccine Deal with Bavarian Nordic

Bristol-Myers Squibb Co. (BMS) said that it has entered into a $1 billion deal with Danish biotechnology company Bavarian Nordic for rights to a late-stage prostate cancer vaccine. The companies entered into an agreement that provides BMS an exclusive option to license and commercialize Prostvac, Bavarian Nordic’s investigational Phase III …

Read More »